A Novel Thromboresistant Hydrogel Material for Vascular Access

Written By Katie Motherway

Access Vascular has published the results of in-vitro and in-vivo studies of HydroPICC. HydroPICC showed an an average of 97% less thrombus accumulation on its surface (based on platelet count)* compared to a standard polyurethane catheter. Read the full results here.

*No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Katie Motherway
Previous

Access Vascular Hosts Podcast on Difficult Venous Access
Next

FDA Clears AVI’s HydroPICC